Study Evaluating the Safety of FXR-450 in Healthy Subjects

NCT00499629 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: FXR 450
DRUG: placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer